News | December 14, 2023
Pfizer expects 2024 revenue between US$ 58.5 to US$ 61.5 billion
Anticipates approx. US$8 billion in revenues for Comirnaty and Paxlovid
Anticipates approx. US$8 billion in revenues for Comirnaty and Paxlovid
Announces changes in the commercial organization to incorporate Seagen and improve focus, speed and execution
First-ever brain chemistry database will allow clinicians to quickly infer brain biomarker data to support the diagnostic process in conditions such as Alzheimer's Disease
We are redesigning Bayer to focus only on what’s essential for our mission, ‘Health for all, hunger for none’”
Three block copolymers added to RESOMER portfolio of bioabsorbable polymers
India confronts alarming rates of eye disorders, propelling the urgency of eyecare awareness
Lupin has been exclusively marketing these brands in the Indian market since July 2021
The market capitalization of the company stood at Rs. 7,000 crore +
The company has received the Establishment Inspection Report (EIR) from the USFDA for the Pre-Approval Inspection (PAI) at a manufacturing site situated at Savli, Vadodara, Gujarat, with Zero 483 observations
This indigenously developed enhanced care technology is designed to continuously monitor and detect early signs of deterioration in a patient's condition
Subscribe To Our Newsletter & Stay Updated
